Correlation Between Anebulo Pharmaceuticals and AnaptysBio
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and AnaptysBio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and AnaptysBio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and AnaptysBio, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and AnaptysBio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of AnaptysBio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and AnaptysBio.
Diversification Opportunities for Anebulo Pharmaceuticals and AnaptysBio
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Anebulo and AnaptysBio is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and AnaptysBio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AnaptysBio and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with AnaptysBio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AnaptysBio has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and AnaptysBio go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and AnaptysBio
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 0.78 times more return on investment than AnaptysBio. However, Anebulo Pharmaceuticals is 1.28 times less risky than AnaptysBio. It trades about -0.15 of its potential returns per unit of risk. AnaptysBio is currently generating about -0.18 per unit of risk. If you would invest 183.00 in Anebulo Pharmaceuticals on August 26, 2024 and sell it today you would lose (37.00) from holding Anebulo Pharmaceuticals or give up 20.22% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. AnaptysBio
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| AnaptysBio |
Anebulo Pharmaceuticals and AnaptysBio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and AnaptysBio
The main advantage of trading using opposite Anebulo Pharmaceuticals and AnaptysBio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, AnaptysBio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will offset losses from the drop in AnaptysBio's long position.| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
| AnaptysBio vs. Crinetics Pharmaceuticals | AnaptysBio vs. Rhythm Pharmaceuticals | AnaptysBio vs. Kura Oncology | AnaptysBio vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |